Found 58 Enz. Inhib. hit(s) with all data for entry = 50002032 TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: 200nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: 400nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: 400nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: 700nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: 700nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: 900nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: 900nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: 1.00E+3nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: 1.10E+3nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: 1.30E+3nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: 1.30E+3nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: 1.70E+3nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: 1.70E+3nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: 1.90E+3nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: 2.00E+3nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: 2.10E+3nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: 2.20E+3nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: 2.70E+3nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: 4.00E+3nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: 4.60E+3nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: 6.80E+3nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: 1.05E+4nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: >3.71E+4nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: >3.71E+4nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: >3.71E+4nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: >3.71E+4nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: >3.71E+4nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: >3.71E+4nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataKi: >3.71E+4nMAssay Description:Competitive inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH aft...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataIC50: 500nMAssay Description:Inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH after 10 mins b...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH after 10 mins b...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH after 10 mins b...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.80E+3nMAssay Description:Inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH after 10 mins b...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH after 10 mins b...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataIC50: 2.30E+3nMAssay Description:Inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH after 10 mins b...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH after 10 mins b...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataIC50: 2.70E+3nMAssay Description:Inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH after 10 mins b...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH after 10 mins b...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataIC50: 3.50E+3nMAssay Description:Inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH after 10 mins b...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataIC50: 3.60E+3nMAssay Description:Inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH after 10 mins b...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataIC50: 4.50E+3nMAssay Description:Inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH after 10 mins b...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataIC50: 4.60E+3nMAssay Description:Inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH after 10 mins b...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH after 10 mins b...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataIC50: 5.50E+3nMAssay Description:Inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH after 10 mins b...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataIC50: 5.70E+3nMAssay Description:Inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH after 10 mins b...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataIC50: 6.00E+3nMAssay Description:Inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH after 10 mins b...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataIC50: 7.30E+3nMAssay Description:Inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH after 10 mins b...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.07E+4nMAssay Description:Inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH after 10 mins b...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.25E+4nMAssay Description:Inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH after 10 mins b...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI [9-251](Staphylococcus aureus)
Novalex Therapeutics
Curated by ChEMBL
Novalex Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.84E+4nMAssay Description:Inhibition of Staphylococcus aureus subsp. aureus Rosenbach ATCC 43300 FabI using crotonyl-CoA as substrate in presence of NADPH/NADH after 10 mins b...More data for this Ligand-Target Pair
